Immunoprecise Antibodies Ltd Strategic Asset Allocation Index

Latest as of April 2024: 0.0%

Immunoprecise Antibodies Ltd strategic asset allocation index. Immunoprecise Antibodies Ltd (IPA) has a Strategic Asset Allocation Index of 0.0% as of April 2024. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $33.92 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Immunoprecise Antibodies Ltd (IPA) balance sheet quality index to measure how much of total assets are equity-financed.

SAAI

0.0%
Strategic Assets / Net Assets

Strategic Assets

$0.00
PP&E + LT Investments

PP&E

$-
USD

Net Assets

$33.92 Million
USD

Strategic Asset Allocation Index of Immunoprecise Antibodies Ltd (2017–2024)

Strategic asset allocation index of Immunoprecise Antibodies Ltd from 2017 to 2024. This chart shows how Immunoprecise Antibodies Ltd's Strategic Asset Allocation Index has evolved across 8 annual periods from 2017 to 2024. As of April 2024, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $33.92 Million USD. Check IPA tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Immunoprecise Antibodies Ltd Strategic Asset Allocation Index by Year (2017–2024)

Immunoprecise Antibodies Ltd strategic asset allocation index by year from 2017 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for Immunoprecise Antibodies Ltd from 2017 to 2024, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Immunoprecise Antibodies Ltd worth.

Year SAAI Strategic Assets (USD) PP&E LT Investments Net Assets Change (pp)
2024 0.0% $0.00 $- $0.00 $33.92 Million ▼ -18.2 pp
2023 18.2% $10.51 Million $10.39 Million $115.00K $57.80 Million ▲ +13.6 pp
2022 4.6% $3.48 Million $3.34 Million $142.00K $75.28 Million ▼ -2.6 pp
2021 7.3% $4.13 Million $4.02 Million $111.00K $56.92 Million ▼ -13.8 pp
2020 21.1% $3.18 Million $3.06 Million $118.90K $15.09 Million ▲ +12.0 pp
2019 9.1% $1.65 Million $1.56 Million $90.40K $18.07 Million ▼ -4.0 pp
2018 13.1% $1.67 Million $1.58 Million $90.40K $12.70 Million ▼ -7.7 pp
2017 20.8% $644.58K $644.58K $- $3.09 Million —
pp = percentage points